COVID-19 trials registries data warehouse

http://en.irct.ir/trial/47279

GHolamreza Pouladfar

alborzicmrc@sums.ac.ir

2020-05-18

Completed

RCT

Randomized

Parallel

Blind label

multi-center

Prevention

Healthcare workers potentially exposed to patient with COVID-19 infection in hospitals Over 18 years of age Complete the consent form with date and signature Male and female

Allergy to the BCG vaccine or any BCG vaccine contraindication Fever (>38 C) within the past 24 hours or generalised skin diseases such as infection, eczema, dermatitis or psoriasis at or near the site of vaccination. Pregnancy Cases with active or latent Mycobacterium tuberculosis Known HIV infection Individuals with any serious underlying illness (such as malignancy) except those with cardiovascular disease, hypertension, diabetes, and/or chronic respiratory disease if they are not immunocompromised Live vaccine administered for 4 weeks prior to randomization Suspected to active viral or bacterial infections Individuals with a SARS-CoV-2 positive test result Severely immunocompromised subject or who has taken immunosuppressive therapy in the last years

2

Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Mdical Sciences

18

100

Iran

Health workers

N/A

500

COVID-19 infection Severe COVID-19 disease

Phase 3

[{"arm_notes": "1", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "1", "treatment_id": 186, "treatment_name": "Bcg vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}]